These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21882109)

  • 1. Study design and simulation approach.
    Läer S; Meibohm B
    Handb Exp Pharmacol; 2011; 205():125-48. PubMed ID: 21882109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical development of pediatric pharmacology.
    Seyberth HW; Rane A; Schwab M
    Handb Exp Pharmacol; 2011; 205():v-vi. PubMed ID: 22046631
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiologically based pharmacokinetic (PBPK) modeling in children.
    Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
    Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modelling.
    Gieschke R; Reigner BG; Steimer JL
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):469-74. PubMed ID: 9352398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small sample approach, and statistical and epidemiological aspects.
    Offringa M; van der Lee H
    Handb Exp Pharmacol; 2011; 205():181-202. PubMed ID: 21882112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge-driven approaches for the guidance of first-in-children dosing.
    Edginton AN
    Paediatr Anaesth; 2011 Mar; 21(3):206-13. PubMed ID: 21129100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction of clinical efficacy.
    Michelson S; Sehgal A; Friedrich C
    Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental pharmacokinetics.
    van den Anker JN; Schwab M; Kearns GL
    Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for modeling and simulation to design clinical investigations in children.
    Jadhav PR; Kern SE
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):121S-129S. PubMed ID: 20881225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics and dynamics of neonatal and pediatric pharmacology.
    Seyberth HW; Kauffman RE
    Handb Exp Pharmacol; 2011; 205():3-49. PubMed ID: 21882104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of modeling and simulation in pediatric investigation plans.
    Manolis E; Osman TE; Herold R; Koenig F; Tomasi P; Vamvakas S; Saint Raymond A
    Paediatr Anaesth; 2011 Mar; 21(3):214-21. PubMed ID: 21244569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of paediatric medicines: concepts and principles.
    Rose K; Della Pasqua O
    Handb Exp Pharmacol; 2011; 205():111-24. PubMed ID: 21882108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of drugs in pediatrics using K-PD models: perspectives.
    Tod M
    Fundam Clin Pharmacol; 2008 Dec; 22(6):589-94. PubMed ID: 19049659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The virtual laboratory approach to pharmacokinetics: design principles and concepts.
    Huisinga W; Telgmann R; Wulkow M
    Drug Discov Today; 2006 Sep; 11(17-18):800-5. PubMed ID: 16935747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates.
    Jamei M; Dickinson GL; Rostami-Hodjegan A
    Drug Metab Pharmacokinet; 2009; 24(1):53-75. PubMed ID: 19252336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Using CTS and PK-PD models to predict the effect of uncertainty about population parameters on clinical trial power].
    Zhu L; Shi X; Liu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):42-6, 62. PubMed ID: 19334551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles of therapeutic drug monitoring.
    Zhao W; Jacqz-Aigrain E
    Handb Exp Pharmacol; 2011; 205():77-90. PubMed ID: 21882106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosimulation software is changing research.
    Ho RL; Bartsell LT
    Biotechnol Annu Rev; 2004; 10():297-302. PubMed ID: 15504712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.